FibroGen Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
102,170.00
137,601.00
180,828.00
179,577.00
125,668.00
212,958
SG&A Expense
105,035.00
183,233.00
252,774.00
227,191.00
242,178.00
293,089
EBIT
7,949.00
50,102.00
77,625.00
53,654.00
122,609.00
86,693
Non Operating Income/Expense
156.00
16.00
3,121.00
2,628.00
6,433.00
11,568
Interest Expense
10,702.00
11,108.00
11,033.00
10,725.00
9,706.00
10,991
Pretax Income
14,943.00
59,504.00
85,537.00
61,751.00
125,882.00
86,116
Income Tax
-
-
242.00
71.00
321.00
304
Consolidated Net Income
14,943.00
59,504.00
85,779.00
61,680.00
126,203.00
86,420
Net Income
14,943.00
59,504.00
85,779.00
61,680.00
126,203.00
86,420
Net Income After Extraordinaries
14,943.00
59,504.00
85,779.00
61,680.00
126,203.00
86,420
Net Income Available to Common
14,943.00
59,504.00
85,779.00
61,680.00
126,203.00
86,420
EPS (Basic)
0.26
3.17
1.42
0.98
1.73
1.03
Basic Shares Outstanding
56,736.90
18,775.00
60,337.00
62,744.00
72,987.00
84,062
EPS (Diluted)
0.26
3.17
1.42
0.98
1.73
1.03
Diluted Shares Outstanding
56,736.90
18,775.00
60,337.00
62,744.00
72,987.00
84,062
EBITDA
2,865.00
45,632.00
71,946.00
47,614.00
116,510.00
80,131
Non-Operating Interest Income
3,552.00
1,690.00
-
-
-
-
About FibroGen
View Profile
